Early stage IT and Healthcare Investing

COR Therapeutics

portfoliocompanies

company snapshot

COR Therapeutics

COR was funded to develop and commercialize innovative pharmaceutical products for the treatment and prevention of severe cardiovascular diseases, such as unstable angina, acute ischemic coronary syndrome and stroke. COR went public in 1991 and was acquired by Millennium in 2001.

website
www.millennium.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share